The randomized, single‐ and multiple‐ ascending dose studies of the safety, tolerability, pharmacokinetics of <scp>CSPCHA115</scp> in healthy Chinese subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The randomized, single‐ and multiple‐ ascending dose studies of the safety, tolerability, pharmacokinetics of CSPCHA115 in healthy Chinese subjects

Published:2022-12-09 Issue:3 Volume:16 Page:447-458
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Jing Shan¹^ORCID,Liu Wenfang¹,Yang Kexu¹,Lin Yang¹,Yao Xuekun²,Sun Guilan²

Affiliation:

1. Clinical Pharmacology Centre, Beijing Anzhen Hospital Capital Medical University Beijing China

2. Clinical Science Division CSPC Pharmaceutical Group Co., Ltd. Shijiazhuang China

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13455

Reference33 articles.

1. A summary of the new GINA strategy: a roadmap to asthma control

2. Epidemiology of Asthma in Children and Adults

3. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study

4. Chinese expert consensus on diagnosis and management of severe asthma

5. Global strategy for asthma management and prevention: GINA executive summary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP